Back to search

Aristotle University Of Thessaloniki (AUTH)

Η συμβολή της ραδιοϊσοτοπικής τομογραφικής απεικόνισης (SPECT) με ⁹⁹ᵐTc-depreotide και ²⁰¹Tl-chloride στην εκτίμηση του καρκίνου του πνεύμονα: σύγκριση με άλλες μεθόδους

Abstract

dc:description

Purpose: This study evaluates and compares the diagnostic performance of ⁹⁹ᵐTc-depreotide and ²⁰¹Tl-chloride single photon emission computerized tomography (SPECT) in the characterisation of pulmonary lesions suspect for malignancy. It also compares the adequacy of diagnostic information provided from clinical and radiological data to that from the radionuclide methods, by means of calculated probability of malignancy, and evaluates the incremental diagnostic value that nuclear medicine methods provide. Patients and method: Fifty-seven pulmonary lesions, from 33 patients, suspected for lung cancer in computed tomography (CT), were assessed by ⁹⁹ᵐTc-depreotide and ²⁰¹Tl-chloride SPECT. Early and delayed tomographic studies of both agents were performed, 15 min and 3 hrs after i.v. injection of the radiopharmaceuticals. Reconstructed images were assessed visually and semiquantitatively, by calculating the tumour to normal (T/N) lung activity ratio (mean counts/pixel) for both early (early ratio, ER) and delayed (delayed ratio, DR) imaging. The retention index (RI) was also calculated: RI = ((DR-ER)/ER) x 100. A final diagnosis was reached for all lesions, based on either histological examination or prolonged clinical and radiological follow-up. The probability of malignancy was calculated for all lesions, from the likelihood ratios (LR) of the clinical and radiological characteristics (CR) of each lesion, as these are recorded in the literature. LRs and corresponding probabilities of malignancy were also calculated from the results of radionuclide studies, for both visual and semiquantitative assessment. Probabilities of malignancy from clinical and radiological characteristics and from radionuclide methods, as well as their combinations, were compared to each other. Results: Twenty-three lesions were characterized malignant and 34 benign. In visual analysis, all malignant lesions accumulated both tracers providing sensitivity and negative predictive values of 100%. However, false positive interpretations resulted in specificity values of 64.7% and 67.6% for ⁹⁹ᵐTc-depreotide and ²⁰¹Tl-chloride respectively. ER and DR of both agents, as well as RI of ⁹⁹ᵐTc-depreotide, were significantly higher in malignant, compared to benign lesions. In defining thresholds of abnormality from the coordinate points of the ROC curve, a significant increase in specificity was observed for both tracers in both scan phases (91.2% for all), as compared to visual analysis (p<0.01), without significant loss of sensitivity. There was no significant difference in the diagnostic performance between semiquantitative indices of both ²⁰¹Tl-chloride and ⁹⁹ᵐTc-depreotide . There was no statistically significant difference between the probability of malignancy calculated from the CR characteristics and that derived from visual assessment of nuclear studies, their combination with CR data and the semiquantitative analysis of ²⁰¹Tl-chloride alone. However, the combination of semiquantitative analysis of both agents with CR characteristics, as well as semiquantitative assessment of ⁹⁹ᵐTc-depreotide by itself, showed statistically significantly different probability of malignancy, compared to that derived from CR data alone. Semiquantitative assessment of ⁹⁹ᵐTc-depreotide eliminated non diagnostic studies, i.e. intermediate probability, while correctly stratifying to low probability 25% of the high probability lesions. Conclusion: This study demonstrates that both ⁹⁹ᵐTc-depreotide and ²⁰¹Tl-chloride SPECT are highly efficient and equally effective in the non-invasive determination of lung malignancy. The specificity of both techniques is significantly improved by quantifying radiopharmaceutical accumulation in the pulmonary lesions, thus reducing false positive results and consequently unnecessary invasive diagnostic techniques. The diagnostic value of CR characteristics, as evaluated by the calculated probability of malignancy, is not sufficient for the safe exclusion of lung cancer. Valuable incremental dignostic information results from the combination of CR data with the semiquantitative assessment of both radiopharmaceuticals. Semiquantitative analysis of ⁹⁹ᵐTc-depreotide, however, has the best diagnostic performance, especially for the lesions of intermediate and high probability of malignancy. The use of radionuclide tests and their appropriate combination with clinical and radiological information could have a valuable contribution to the effective diagnostic work up of patients with pulmonary lesions suspect for malignancy.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Boundas, D.
  • Μπούντας, Δημήτριος

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19343

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Boundas, D.; Μπούντας, Δημήτριος. Η συμβολή της ραδιοϊσοτοπικής τομογραφικής απεικόνισης (SPECT) με ⁹⁹ᵐTc-depreotide και ²⁰¹Tl-chloride στην εκτίμηση του καρκίνου του πνεύμονα: σύγκριση με άλλες μεθόδους. Aristotle University Of Thessaloniki (AUTH), 2008. http://hdl.handle.net/10442/hedi/19343